Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating Activities
Net income	$ 985,515	$ 3,386,418
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	202,843	139,324
Amortization, net	272,617	161,803
Amortization related to postretirement benefits obligation	554	1,193
Share-based compensation expense related to stock options	21,572	17,737
Increase in allowance for doubtful accounts on premiums receivable	380,006	95,716
Net realized gain on investments	(492,137)	(16,344)
Net earnings from other investments	(196,406)	(379,696)
Provision (benefit) for claims	2,375,383	(389,058)
(Benefit) provision for deferred income taxes	(4,000)	799,000
Changes in assets and liabilities:
Decrease in receivables	889,447	1,537,769
Decrease in other assets	46,072	214,586
Increase in current income taxes recoverable	(309,273)	0
Decrease in accounts payable and accrued liabilities	(4,833,772)	(2,547,550)
Decrease in current income taxes payable	0	(962,058)
Payments of claims, net of recoveries	(1,270,383)	(380,942)
Net cash (used in) provided by operating activities	(1,931,962)	1,677,898
Investing Activities
Purchases of available-for-sale securities	(2,242,850)	(9,601)
Purchases of short-term securities	(3,117,062)	(6,286,175)
Purchases of other investments	(556,563)	(321,231)
Proceeds from sales and maturities of available-for-sale securities	3,328,386	4,470,026
Proceeds from sales and maturities of short-term securities	2,102,435	14,326
Proceeds from sales and distributions of other investments	241,977	504,500
Proceeds from sales of other assets	0	4,832
Purchases of property	(594,507)	(273,381)
Net cash used in investing activities	(838,184)	(1,896,704)
Financing Activities
Repurchases of common stock	(39,825)	(114,958)
Exercises of stock options and SARs	(19)	166,585
Payments of Ordinary Dividends, Noncontrolling Interest	(64,020)	0
Excess Tax Benefit from Share-based Compensation, Financing Activities	2,889	22,439
Dividends paid	(162,946)	(163,677)
Net cash used in financing activities	(263,921)	(89,611)
Net Decrease in Cash and Cash Equivalents	(3,034,067)	(308,417)
Cash and Cash Equivalents, Beginning of Period	23,626,761	20,810,018
Cash and Cash Equivalents, End of Period	20,592,694	20,501,601
Cash Paid During the Year for:
Income tax payments, net	681,700	1,507,100
Non cash net unrealized gain on investments, net of deferred tax provision of $(7,267) and $(823,883) for 2014 and 2013, respectively	$ (3,101)	$ (1,558,762)